Molecule intelOpportunity: ModerateEssential

Enalapril

89 brands · 36 companies · product forms

ATC: C09AA02

Opportunity snapshot

Launch attractiveness
37
Market saturation
88
Price room
100
Regulatory risk
0
89
brands
36
companies
Rs 128.79
median price
96
price points
25.57x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 6%

Price room

Across observed sources and strengths
CheapestRs 33.5
MedianRs 128.79
Most expensiveRs 856.6
Spread25.57×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 25.57x across 96 trusted points (Rs 33.5-856.6). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Enalapril — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(25) + 25% price-variation(100) + 20% low-competition(12) + 15% supply-disruption(0), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

36 canonical companies and 89 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 25.57x across 96 trusted points (Rs 33.5-856.6). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Full coverage.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.